You are subscribed to one of the following page update alerts:
Vaccine Code Set Update Publication Date: April 14, 2022
The individual filenames included in this distribution contain the publication date (20220414)
Release Notes: This release includes updates for all vaccine codes except Vaccine Information Statement (VIS) codes. In addition, the COVID-19 US Vaccine Codes table and the COVID-19 Non-US Vaccine Codes table have been updated to reflect changes in this release. IIS COVID-19 Vaccine Related Code | CDC
Release notes are designed as a guide to highlight changes that have been made to the vaccine codes since the last publication. They should not be used as the primary source of code information. The vaccine code files themselves should be utilized.
General Note Regarding This Release: Codes with “Last Update” dates from March 15, 2022, through April 14, 2022, reflect the changes and additions in this release.
This release includes the following code set updates.
Vaccine Code Set Updates Not Related to COVID-19
- Retired NDCs
COVID-19 Related Code Updates
- Moderna Vaccine Codes for Pediatric Vaccines Added (pre-EUA)
- Sanofi Pasteur Vaccine NDC codes Added (pre-EUA)
- Non-US COVID-19 Vaccine Codes Added
Vaccine Code Set Updates Not Related to COVID-19
The following NDCs have been retired effective 3/15/2022 from the FDA files:
Table 1: Retired NDCs
Proprietary Name | Sale Labeler | Sale NDC10 and
NDC11 | Use NDC10 and
NDC11 | CVX Code | MVX Code |
|---|
FluMist Quadrivalent | MedImmune, LLC | 66019-308-10
66019-0308-10 | 66019-308-01
66019-0308-01 | 149 | MED |
|---|
COVID-19 Related Code Updates
COVID-19 vaccine codes and crosswalks are provided in anticipation of potential vaccine availability under an approved Biologics License Application (BLA), Emergency Use Authorization (EUA), or as a potential vaccine submission for EUA (Pre-EUA). Codes will become effective for US vaccine administrations only upon EUA issuance and/or BLA approval of COVID-19 vaccine(s) by the FDA. All CVX codes are associated to the new Vaccine Group "COVID-19." CPT codes shown are product codes. CPT administrative codes for doses are available on the AMA website. CPT product codes are added as the AMA approves and makes them available.- Moderna Vaccine Codes for Pediatric Vaccines Added (pre-EUA)
Moderna is working with FDA to submit for two new pediatric products under EUA:
- Vaccine for children 6 years to < 12 years
- Vaccine for children 6 months to < 6 years
Two new CVX codes have been added. At this time, NDC and CPT codes are not available for crosswalks.
Table 2: New CVX Codes for Moderna Pediatric COVID-19 Vaccines (pre-EUA)
CVX Code | CVX Short Description | Full Vaccine Name | Note | Vaccine Status |
|---|
227 | COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose | Pre-EUA Moderna Pediatric 6yr to<12 yr vaccine 2.5 mL vial, 50 mcg/0.5 mL dose | Active |
|---|
228 | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose | Pre-EUA Moderna Pediatric 6mo to<6yr 2.5 mL vial, 25 mcg/0.25 mL dose | Active |
|---|
- Sanofi Pasteur Vaccine NDC Codes Added (pre-EUA)
NDC codes have now been associated to the COVID-19 Booster CVX Codes. The NDCs listed in the table below represent the Sanofi booster antigen only. AMA CPT codes are not yet available for this code set release.
Table 3: New NDCs for Pre-EUA Authorized Sanofi COVID-19 Booster
CVX Code | Sale Labeler | MVX Code | Sale NDC10 and
NDC11 | Use NDC10 and
NDC11 | Note |
|---|
225 | Sanofi Pasteur Inc. | PMC | 49281-618-20
49281-0618-20 | 49281-618-20
49281-0618-78 | Antigen component only
– must be mixed with
GSK AS03 adjuvant |
|---|
- Non-US COVID-19 Vaccine Codes Added
Six new non-US CVX codes have been added. Of these, none are WHO authorized; one non-US vaccine for Medicago/Covifenz, is approved and manufactured in Canada and has been recognized by ACIP as counting towards immunity in the US. An MVX code, MDO, and a product code for Covifenz have been added to support potential reporting.
Table 4: New Non-US COVID-19 Vaccine CVX Codes
CVX Code | CVX Short Description | Full Vaccine Name | Note | Vaccine Status | MVX Code |
|---|
512 | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) | Pandemic Non-US Vaccine not Authorized by WHO - ACIP does recognize towards immunity in US | Non-US | MDO |
|---|
513 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) | Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US | Non-US | N/A |
|---|
514 | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) | Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US | Non-US | `N/A |
|---|
515 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) | Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US | Non-US | N/A |
|---|
516 | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US | Non-US | N/A |
|---|
517 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) | Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US | Non-US | N/A |
|---|
